NYLT
ELV icon

New York Life Trust’s Elevance Health ELV Stock Holding History

New York Life Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$7K Sell
44
-899
-95% -$143K 0.34% 94
2016
Q4 		$136K Sell
943
-32
-3% -$4.29K 0.65% 37
2016
Q3 		$122K Buy
975
+19
+2% +$2.45K 0.6% 42
2016
Q2 		$126K Sell
956
-53
-5% -$7.25K 0.61% 39
2016
Q1 		$140K Buy
1,009
+402
+66% +$53.7K 0.61% 39
2015
Q4 		$85K Sell
607
-442
-42% -$60.9K 0.36% 106
2015
Q3 		$147K Buy
1,049
+31
+3% +$4.66K 0.65% 41
2015
Q2 		$167K Sell
1,018
-99
-9% -$15.8K 0.69% 40
2015
Q1 		$172K Sell
1,117
-142
-11% -$20.2K 0.68% 39
2014
Q4 		$158K Sell
1,259
-36
-3% -$4.45K 0.62% 50
2014
Q3 		$155K Sell
1,295
-65
-5% -$7.46K 0.64% 45
2014
Q2 		$146K Sell
1,360
-46
-3% -$4.74K 0.62% 49
2014
Q1 		$140K Sell
1,406
-19
-1% -$1.72K 0.62% 50
2013
Q4 		$132K Buy
1,425
+5
+0.4% +$444 0.6% 46
2013
Q3 		$119K Sell
1,420
-250
-15% -$21.4K 0.6% 50
2013
Q2 		$137K Buy
+1,670
New +$125K 0.63% 42

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

New York Life Trust's ELV Position: Q1 2017 in Review

New York Life Trust reduced its Elevance Health (ELV) stake by 95% in Q1 2017, selling an estimated $143K and leaving 44 shares worth $7K. The position accounts for 0.34% of the portfolio, ranked #94.

New York Life Trust first reported a position in ELV in Q2 2013 and has held it in 16 quarters since. The position peaked at $172K in Q1 2015. 795 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

  • New York Life Trust held 44 shares of Elevance Health worth $7K as of Q1 2017.
  • New York Life Trust sold 899 Elevance Health shares in Q1 2017, an estimated $143K.
  • Elevance Health made up 0.34% of New York Life Trust's portfolio in Q1 2017, its #94 holding.
  • New York Life Trust first reported a position in Elevance Health in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Elevance Health position peaked at $172K in Q1 2015.
  • 795 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.